A phase II trial of biweekly gemcitabine and paclitaxel (GEMTAX) combination in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): A Southwest Oncology Group study.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 5555-5555
Author(s):  
K. E. Bickel ◽  
F. P. Worden ◽  
J. Moon ◽  
O. Kucuk ◽  
R. H. Wheeler ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Metastatic Squamous Cell Carcinoma ◽  
Southwest Oncology Group Study

Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: A southwest oncology group study

1995 ◽  
Vol 13 (1) ◽  
pp. 67-71 ◽  
Author(s):  
Stephen K. Williamson ◽  
John J. Crowley ◽  
Robert B. Livingston ◽  
Timothy J. Panella ◽  
John Wendall Goodwin
Keyword(s):  
Cost Analysis ◽  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document